Evidence map›Paper›PMID 29262600›Full record

ArticleOncotarget2017

Xiaopeng Li, Ming Li, JiaLi Chen, Hua Dai, Liang Wang, Ying Xiong, Yuanbin Zhong, Lunli Zhang

RetractedAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development.Journal of experimental & clinical cancer research : CR · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Xiaopeng LiDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China.
Ming LiDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China.
JiaLi ChenDepartment of Function, JiangXi Children's Hospital, Nanchang, JiangXi 330006, China.
Hua DaiDepartment of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China.
Liang WangDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China.
Ying XiongDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China.
Yuanbin ZhongDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China.
Lunli ZhangDepartment of Infectious Disease, The First Affiliated Hospital of Nanchang University, Nanchang, JiangXi 330006, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver cancer is one of the most serious cancers all over the world. Liver tumor initiating cells (TICs) account for tumor initiation and metastasis. However, the regulatory mechanism of liver TICs remains unclear. Here we found long noncoding RNA

Indexed as

EZH2liver TICsSAMMSONself-renewalWnt/β-catenin

Identifiers

PMID29262600
PMCPMC5732766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.